Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Sequence-specific anti-HIV activity reported for the oligodeoxynucleotide SA-1042

Dec. 5, 1997

Actinomycin D: new use in AIDS therapy available for licensing

Dec. 4, 1997

Antiviral thiazolidines and thiazolidinones from INSERM

Dec. 4, 1997

ID Vaccine acquires rights to new AIDS vaccine

Dec. 3, 1997

Combivir recommended for approval in Europe

Nov. 24, 1997

DCK analogues with potent and selective anti-HIV activity

Nov. 24, 1997

Mitsui Norin discovers natural antiviral/antitumor agent

Nov. 24, 1997

United Biomedical and California lab to collaborate on novel HIV therapeutic

Nov. 20, 1997

Thalidomide proves effective in HIV-associated proctitis

Nov. 20, 1997

Cell Genesys issued U.S. patent for gene therapy

Nov. 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...